NCT04428073View on ClinicalTrials.gov

Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

PHASE1UnknownINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

December 31, 2021

Conditions
COVID
Interventions
BIOLOGICAL

Covax-19™

Therapeutic vaccine for SARS-CoV-2 infection

Sponsors
All Listed Sponsors
lead

GeneCure Biotechnologies

INDUSTRY